Page 36 - BH-3-1

Brain & Heart Cardioneuroablation for VMB

doi: 10.1016/j.ijcard.2019.12.003 syncope and symptomatic bradyarrhythmias: The CNA-
FWRD Registry [published online Mar 18, 2014]. J Interv
48. Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of Card Electrophysiol. 2024.
the canine atria and sinus and atrioventricular nodes. The
third fat pad. Circulation. 1997;95(11):2573-2584. doi: 10.1007/s10840-024-01789-9
doi: 10.1161/01.cir.95.11.2573 51. Chakraborty P, Chen PS, Gollob MH, Olshansky B, Po SS.
Potential consequences of cardioneuroablation for vasovagal
49. Hu F, Zheng L, Liu S, et al. The impacts of the ganglionated syncope: A call for appropriately designed, sham-controlled
plexus ablation sequence on the vagal response, heart rate, clinical trials. Heart Rhythm. 2024;21(4):464-470.
and blood pressure during cardioneuroablation. Auton
Neurosci. 2021;233:102812. doi: 10.1016/j.hrthm.2023.12.004
52. NCT05855603. Cardioinhibitory Reflex Syncope. Permanent
doi: 10.1016/j.autneu.2021.102812
Pacemaker Therapy or Cardioneuroablation? (PANACEA).
50. Aksu T, Tung R, De Potter T, et al. Cardioneuroablation Available from: https://clinicaltrials.gov/ [Last accessed on:
for the management of patients with recurrent vasovagal 2024 Dec 10].

Volume 3 Issue 1 (2025) 11 doi: 10.36922/bh.4824